AIMS: Increased glucose excursions and postprandial hyperglycaemia have been suggested as unique risk factors for cardiovascular disease (CVD) and mortality in patients with diabetes mellitus. Much of the evidence is based on a single 2 h glucose value after oral glucose tolerance testing in epidemiological studies. We examined the association between various indices of glycaemia measured during everyday activities and metabolic CVD risk factors in the A1C-Derived Average Glucose (ADAG) study. METHODS: Participants (268 with type 1 diabetes, 159 with type 2 diabetes) completed 16 weeks of intensive continuous glucose monitoring (CGM) and self-monitoring of blood glucose (SMBG). From these data, common indices of postprandial glycaemi...
Coronary artery disease and type 2 diabetes are chronic diseases of substantial and growing prevalen...
OBJECTIVE: The A1C-Derived Average Glucose (ADAG) study demonstrated a linear relationship between H...
BackgroundThe role of glycemic variability (GV) in development of cardiovascular diseases remains co...
AIMS: Increased glucose excursions and postprandial hyperglycaemia have been suggested as unique ri...
OBJECTIVE: Various methods are used to quantify postprandial glycemia or glucose variability, but f...
HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors tha...
We tested whether average monthly glycemic burden (AMGB), a marker of hy-perglycemia that is a funct...
Aims/hypothesisIt is not known whether mean blood glucose (MBG) predicts the risk of macrovascular c...
To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour ...
To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour ...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
OBJECTIVE—Various methods are used to quantify postpran-dial glycemia or glucose variability, but fe...
OBJECTIVE—We compared A1C and fasting plasma glucose (FPG) in predicting cardiovas-cular disease (CV...
OBJECTIVE—The A1C-Derived Average Glucose (ADAG) study demonstrated a linear re-lationship between H...
Whilst the interplay between type 2 diabetes and cardiovascular disease (CVD) has been recognised fo...
Coronary artery disease and type 2 diabetes are chronic diseases of substantial and growing prevalen...
OBJECTIVE: The A1C-Derived Average Glucose (ADAG) study demonstrated a linear relationship between H...
BackgroundThe role of glycemic variability (GV) in development of cardiovascular diseases remains co...
AIMS: Increased glucose excursions and postprandial hyperglycaemia have been suggested as unique ri...
OBJECTIVE: Various methods are used to quantify postprandial glycemia or glucose variability, but f...
HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors tha...
We tested whether average monthly glycemic burden (AMGB), a marker of hy-perglycemia that is a funct...
Aims/hypothesisIt is not known whether mean blood glucose (MBG) predicts the risk of macrovascular c...
To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour ...
To determine the association between HbA1c, fasting plasma glucose (FPG), 1-hour (1 hPG) and 2-hour ...
Trials of intensive glucose control have not improved cardiovascular disease (CVD) risk in populatio...
OBJECTIVE—Various methods are used to quantify postpran-dial glycemia or glucose variability, but fe...
OBJECTIVE—We compared A1C and fasting plasma glucose (FPG) in predicting cardiovas-cular disease (CV...
OBJECTIVE—The A1C-Derived Average Glucose (ADAG) study demonstrated a linear re-lationship between H...
Whilst the interplay between type 2 diabetes and cardiovascular disease (CVD) has been recognised fo...
Coronary artery disease and type 2 diabetes are chronic diseases of substantial and growing prevalen...
OBJECTIVE: The A1C-Derived Average Glucose (ADAG) study demonstrated a linear relationship between H...
BackgroundThe role of glycemic variability (GV) in development of cardiovascular diseases remains co...